Domestic Use Surpasses Export Due to China's Vaccine Hesitancy

[Image source=Yonhap News]

[Asia Economy Reporter Cho Hyun-ui] It has been revealed that the export volume of Chinese-made COVID-19 vaccines exceeds the domestic usage. This is because the Chinese government is actively conducting vaccine diplomacy, and Chinese citizens are skeptical about the effectiveness of their domestic vaccines.

According to the South China Morning Post (SCMP) in Hong Kong on the 16th, China has exported at least 46 million doses as of the previous day and plans to export even more soon.

The number of COVID-19 vaccine doses registered in China was 4,052 as of the 9th. SCMP explained, "This means that 3 doses have been administered per 100 people in China."

It added, "Due to Chinese citizens doubting the effectiveness of domestic vaccines and even avoiding vaccination itself, domestic consumption is not progressing as quickly as the authorities had planned."

In fact, a survey conducted last month by the Shanghai Center for Disease Control and Prevention targeting 1.77 million residents showed that about half of the respondents said they did not want to receive the COVID-19 vaccine.

A Beijing resident told SCMP in an interview, "I refused the vaccination supported by my company," adding, "The coronavirus keeps mutating, and the clinical trial results of the vaccine are insufficient, with the duration of its effectiveness also unclear."

This content was produced with the assistance of AI translation services.